1. Home
  2. TECH vs KNX Comparison

TECH vs KNX Comparison

Compare TECH & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • KNX
  • Stock Information
  • Founded
  • TECH 1976
  • KNX 1989
  • Country
  • TECH United States
  • KNX United States
  • Employees
  • TECH N/A
  • KNX N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • KNX Trucking Freight/Courier Services
  • Sector
  • TECH Health Care
  • KNX Industrials
  • Exchange
  • TECH Nasdaq
  • KNX Nasdaq
  • Market Cap
  • TECH 7.9B
  • KNX 7.2B
  • IPO Year
  • TECH 1989
  • KNX 1994
  • Fundamental
  • Price
  • TECH $51.61
  • KNX $46.07
  • Analyst Decision
  • TECH Buy
  • KNX Buy
  • Analyst Count
  • TECH 10
  • KNX 16
  • Target Price
  • TECH $73.44
  • KNX $51.47
  • AVG Volume (30 Days)
  • TECH 2.3M
  • KNX 3.2M
  • Earning Date
  • TECH 05-07-2025
  • KNX 04-23-2025
  • Dividend Yield
  • TECH 0.62%
  • KNX 1.55%
  • EPS Growth
  • TECH N/A
  • KNX 37.21
  • EPS
  • TECH 0.83
  • KNX 0.93
  • Revenue
  • TECH $1,208,770,000.00
  • KNX $7,411,973,000.00
  • Revenue This Year
  • TECH $8.19
  • KNX $4.64
  • Revenue Next Year
  • TECH $8.61
  • KNX $7.93
  • P/E Ratio
  • TECH $62.17
  • KNX $49.82
  • Revenue Growth
  • TECH 4.72
  • KNX 1.16
  • 52 Week Low
  • TECH $46.44
  • KNX $36.69
  • 52 Week High
  • TECH $85.57
  • KNX $61.51
  • Technical
  • Relative Strength Index (RSI)
  • TECH 49.54
  • KNX 63.71
  • Support Level
  • TECH $46.77
  • KNX $40.04
  • Resistance Level
  • TECH $54.40
  • KNX $49.39
  • Average True Range (ATR)
  • TECH 2.03
  • KNX 1.44
  • MACD
  • TECH 0.70
  • KNX 0.98
  • Stochastic Oscillator
  • TECH 63.43
  • KNX 71.45

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About KNX Knight-Swift Transportation Holdings Inc.

Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the U.S. Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.

Share on Social Networks: